Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

[Scope of the latest RE-LY substudies: clinical implications].

Ruiz-Giménez Arrieta N.

Rev Clin Esp. 2012 Mar;212 Suppl 2:4-14. doi: 10.1016/S0014-2565(12)70013-9. Spanish.

PMID:
23117716
2.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
3.

New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.

Barrios V, Escobar C.

Expert Opin Pharmacother. 2012 Dec;13(18):2649-61. doi: 10.1517/14656566.2012.749860. Epub 2012 Nov 20. Review.

PMID:
23167273
4.

Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.

Siddiqui FM, Qureshi AI.

Expert Opin Pharmacother. 2010 Jun;11(8):1403-11. doi: 10.1517/14656566.2010.482931. Review.

PMID:
20446854
5.

Should dabigatran replace warfarin for stroke prevention in AF?

[No authors listed]

Drug Ther Bull. 2011 Oct;49(10):114-7. doi: 10.1136/dtb.2011.02.0060. Review.

PMID:
21994438
6.

Dabigatran etexilate in atrial fibrillation.

Vora A.

J Assoc Physicians India. 2013 Dec;61(12):900-2. Review.

PMID:
24968547
7.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24. Review.

PMID:
22537354
8.

Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial.

DiNicolantonio JJ.

Expert Opin Pharmacother. 2012 Jun;13(8):1101-11. doi: 10.1517/14656566.2012.671809. Epub 2012 Mar 22. Review.

PMID:
22435606
9.

Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?

Lip GY, Lane DA.

Am J Med. 2010 Sep;123(9):785-9. doi: 10.1016/j.amjmed.2010.01.031. Epub 2010 Jul 23. Review.

PMID:
20655037
10.
11.

Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.

Bovio JA, Smith SM, Gums JG.

Ann Pharmacother. 2011 May;45(5):603-14. doi: 10.1345/aph.1P644. Epub 2011 May 3. Review.

PMID:
21540406
12.

Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation.

Galanis T, Merli GJ.

Hosp Pract (1995). 2013 Feb;41(1):26-36. doi: 10.3810/hp.2013.02.1010. Review.

PMID:
23466965
13.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
14.

Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.

Uchiyama S, Ibayashi S, Matsumoto M, Nagao T, Nagata K, Nakagawara J, Tanahashi N, Tanaka K, Toyoda K, Yasaka M.

J Stroke Cerebrovasc Dis. 2012 Apr;21(3):165-73. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.011. Review.

PMID:
22440950
15.

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.

Berman JP, Halperin JL.

Hosp Pract (1995). 2013 Feb;41(1):37-48. doi: 10.3810/hp.2013.02.1006. Review.

PMID:
23466966
16.

Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.

Agarwal S, Hachamovitch R, Menon V.

Arch Intern Med. 2012 Apr 23;172(8):623-31; discussion 631-3. doi: 10.1001/archinternmed.2012.121. Epub 2012 Mar 26. Review.

PMID:
22450212
17.

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.

Mantha S, Ansell J.

Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28. Review.

PMID:
22740145
18.

Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation.

Liew A, Eikelboom JW, O'Donnell M.

Curr Opin Cardiol. 2012 Jul;27(4):331-9. doi: 10.1097/HCO.0b013e3283540857. Review.

PMID:
22573171
19.

Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?

Escobar C, Barrios V, Jimenez D.

Cardiovasc Ther. 2010 Oct;28(5):295-301. doi: 10.1111/j.1755-5922.2010.00216.x. Epub 2010 Aug 16. Review.

PMID:
20718760
20.

[Preventing stroke by treating atrial fibrillation--new hope with dronedarone and dabigatran?].

Röther J, Laufs U.

Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S55-8. doi: 10.1055/s-0030-1249210. Epub 2010 Mar 10. Review. German.

PMID:
20221980

Supplemental Content

Support Center